Medtronic is upping the ante in a patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic’s InterStim device, an implanted ...

Dr. Keith Roach, M.D. DEAR DR. ROACH: My daughter, who is 50, recently went to a urologist for bladder retention issues. She had several tests performed. My daughter’s doctor told her that the ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. For people dealing with spina bifida, paralysis, and various bladder ...

Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...

Sacral neuromodulation, which is also called interstim, acts to provide a small amount of electrical stimulation to the nerves that run through the tailbone (sacrum) to the bladder. For reasons we do ...

A successful treatment for bladder incontinence has a new twist that makes it accessible to more people. Bladder incontinence is a problem that impacts about 37 million people. One in six Americans ...

It's hard for some folks who suffer illness-related urinary incontinence to judge whether they'll be able to hold it until they get home, or if they should rush to a bathroom now. There might soon be ...

A new implant eliminated bladder cancer in 82% of patients treated The device slowly releases chemo drugs into the bladder Chemo provided by standard means runs through the bladder too quickly to be ...

Medtronic has received Food and Drug Administration approval for a neuromodulation therapy in urge urinary incontinence, the company said Friday. The Altaviva device is inserted near the ankle and ...